How Atlanta’s peptide care routes differ
This guide explains the words, the rules, the visit, and the questions. Nobody here treats patients, and nothing here is sold.
Chapter one · orientation
A peptide is a short string of the same building blocks that proteins are made of, like a few beads cut from a long necklace. Insulin is one peptide.
That word is about chemistry only; whether a given product is approved, safe, or legal is a separate question it leaves open.
That is why the next question matters more than the label: is the product an approved medicine, a compounded medicine made for a patient, or a research chemical offered online?
Three routes
Approved by the FDA
In the United States, tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) both hold FDA approval as medicines, as of September 2026.
Approval covers one named product in one form, such as a certain injection pen or a certain tablet. It is not a blanket approval of every item sold with the same ingredient name.
Route B: custom medicine
Compounding is custom work: a pharmacist or doctor makes the medicine for one patient. It replaces a finished product built by a drug company. A larger compounding business that registers with the FDA, called an outsourcing facility, may also do this work.
As of September 2026, compounded medicines carry no FDA approval. The FDA also does not check them for safety, effectiveness, or quality before they reach buyers.
That does not make all compounding unlawful. It means “compounded” and “FDA-approved” are different claims.
Stop and check
As of September 2026, an online vial marked “research use only” is not a legal route to treatment.
When the FDA sends a seller a warning letter, it looks at the whole sales page and at what is sold alongside the vial, such as mixing water and a dosing guide, to judge whether the seller truly intends the product to be injected by people.
A disclaimer on the label does not turn a treatment product into laboratory material.
What care feels like
A useful visit leaves room for the reason you came, your health history, medicines you already use, and what result you hope for.
The clinician is whoever treats you: a doctor, a nurse practitioner, or a physician assistant. They may need your medical records, an exam, or tests. They may decide a medicine does not fit. A careful “no” is still an answer.
Before the visit ends, ask for the medicine’s generic name, whether the product is approved or compounded, who will make it, the full cost, and what follow-up looks like.
The generic name is the chemical name, such as semaglutide, rather than a brand name such as Wegovy. Write it down and check it against the label when the medicine arrives.
Atlanta means Georgia rules
As of September 2026, a doctor licensed in another state who treats you while you are in Georgia needs a Georgia medical licence or a Georgia telemedicine licence, apart from narrow exceptions.
As of September 2026, Georgia’s telemedicine rule allows online care after a prior in-person exam or at the request of a Georgia clinician who examined you.
The rule also allows it when the clinician’s equipment can examine you as well as an office visit would. The rule does not say which video or camera tools meet that bar, so ask how they plan to examine you.
As of September 2026, the Georgia medical board says that, in general, one in-person exam comes before a first prescription.
This covers controlled drugs, which have extra legal limits, and other prescription-only medicines. The written rules make some exceptions, including a short supply from a doctor covering for your usual one, a documented emergency, and a care relationship set up under Georgia’s telehealth law.
Because of those exceptions, ask the service before you pay whether your first visit can happen online.
Endnotes by chapter